122 related articles for article (PubMed ID: 3839751)
1. Cis-platin in combination with low dose adriamycin and cyclophosphamide in advanced ovarian carcinoma.
Verheijen RH; Beex L; Wagener DJ; Kenemans P
Eur J Gynaecol Oncol; 1985; 6(2):116-20. PubMed ID: 3839751
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy with cis-platin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer.
Colozza M; Gori S; Mosconi AM; Belsanti V; Basurto C; Rossetti R; Di Costanzo F; Buzzi F; Bacchi M; Davis S
Am J Clin Oncol; 1989 Apr; 12(2):137-41. PubMed ID: 2705403
[TBL] [Abstract][Full Text] [Related]
3. [Intermittent administration of the combination chemotherapy with cis-platin, adriamycin and cyclophosphamide (cyclic-PAC chemotherapy) for the ovarian cancers].
Inoue M; Nakanishi K; Nakazawa A; Ogawa H; Shimizu H; Saitoh J; Tanaka Y; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):347-52. PubMed ID: 2358719
[TBL] [Abstract][Full Text] [Related]
4. Results of the combination of cisplatin, adriamycin and cyclophosphamide in the treatment of ovarian carcinoma.
Russo A; Gebbia V; Palmeri S; Geraci P; Maneschi F; Guarnieri G; Carollo F; Leonardi V; Meli M; Gebbia N
Eur J Gynaecol Oncol; 1993; 14(3):228-33. PubMed ID: 8508880
[TBL] [Abstract][Full Text] [Related]
5. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.
Sessa C; Colombo N; Bolis G; Marsoni S; Mangioni C
Cancer Treat Rev; 1991 Mar; 18 Suppl A():37-46. PubMed ID: 1904308
[No Abstract] [Full Text] [Related]
7. Carboplatin (JM 8), adriamycin and cyclophosphamide (JAC) in advanced ovarian carcinoma: a pilot study.
Conte PF; Bruzzone M; Chiara S; Rosso R; Giaccone G; Carnino F; Guercio E; Ragni N; Foglia G; Bentivoglio G
Tumori; 1988 Apr; 74(2):217-20. PubMed ID: 2453091
[TBL] [Abstract][Full Text] [Related]
8. Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens.
Vogl SE; Pagano M; Kaplan BH; Greenwald E; Arseneau J; Bennett B
Cancer; 1983 Jun; 51(11):2024-30. PubMed ID: 6404547
[TBL] [Abstract][Full Text] [Related]
9. Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Eur J Gynaecol Oncol; 1998; 19(1):5-10. PubMed ID: 9476049
[TBL] [Abstract][Full Text] [Related]
10. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin.
Belinson JL; McClure M; Ashikaga T; Krakoff IH
Cancer; 1984 Nov; 54(9):1983-90. PubMed ID: 6548172
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancer.
Verusio C; Bajetta E; Ferrari L; Bartoli C; Valagussa P; Bonadonna G
Am J Clin Oncol; 1988 Aug; 11(4):435-9. PubMed ID: 3407621
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin and cis-platinum in advanced ovarian cancer.
de Gramont A; Drolet Y; Lavoie A; Painchaud M; Blouin R; Tessier C; Ouellet P
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):665-9. PubMed ID: 4040466
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.
Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Willemse PH; Heintz AP; van Lent M; Trimbos JB; Bouma J; Vermorken JB
J Clin Oncol; 1987 Aug; 5(8):1157-68. PubMed ID: 3114434
[TBL] [Abstract][Full Text] [Related]
15. The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).
Hainsworth JD; Jones HW; Burnett LS; Johnson DH; Greco FA
Am J Clin Oncol; 1990 Oct; 13(5):410-5. PubMed ID: 2121019
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced ovarian cancer with combination chemotherapy using cyclophosphamide, adriamycin and cis-platinum.
Milsted R; Sangster G; Kaye S; Calman K; Cordiner J; Soutter W; Barr W; Cunningham D; Soukop M; Kennedy J
Br J Obstet Gynaecol; 1984 Sep; 91(9):927-31. PubMed ID: 6548149
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC).
Diaz-Rubio E; Escudero M; Martin-Jimenez M; Vidart JA; Gonzalez-Larriba JL; Herraiz MA; Lopez Vega JM; Bullon F
Eur J Gynaecol Oncol; 1989; 10(6):424-32. PubMed ID: 2627975
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of advanced ovarian cancer. Göttingen-Hannover studies].
Kühnle H; Hilfrich J
Onkologie; 1985 Dec; 8(6):374-82. PubMed ID: 3912694
[TBL] [Abstract][Full Text] [Related]
19. Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinum.
Mann GJ; Malden LT; Solomon HJ; Tattersall MH
Gynecol Oncol; 1985 Jun; 21(2):215-9. PubMed ID: 3886497
[TBL] [Abstract][Full Text] [Related]
20. High-dose cis-platinum in combination with adriamycin in the treatment of ovarian carcinoma.
Choo YC; Wong LC; Ma HK
Eur J Gynaecol Oncol; 1984; 5(3):203-6. PubMed ID: 6376128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]